Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Viking Therapeutics (VKTX) Amortization - Intangibles (2016 - 2018)

Viking Therapeutics (VKTX) has disclosed Amortization - Intangibles for 5 consecutive years, with $146000.0 as the latest value for Q2 2018.

  • Quarterly Amortization - Intangibles fell 56.68% to $146000.0 in Q2 2018 from the year-ago period, while the trailing twelve-month figure was $146000.0 through Mar 2019, down 86.85% year-over-year, with the annual reading at $404000.0 for FY2018, 68.51% down from the prior year.
  • Amortization - Intangibles hit $146000.0 in Q2 2018 for Viking Therapeutics, down from $258000.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $524977.0 in Q2 2016 to a low of $6379.0 in Q1 2014.
  • Historically, Amortization - Intangibles has averaged $273697.2 across 5 years, with a median of $257000.0 in 2017.
  • Biggest five-year swings in Amortization - Intangibles: skyrocketed 2595.64% in 2015 and later tumbled 56.68% in 2018.
  • Year by year, Amortization - Intangibles stood at $294310.0 in 2014, then decreased by 18.28% to $240516.0 in 2015, then skyrocketed by 79.29% to $431227.0 in 2016, then crashed by 39.94% to $259000.0 in 2017, then plummeted by 43.63% to $146000.0 in 2018.
  • Business Quant data shows Amortization - Intangibles for VKTX at $146000.0 in Q2 2018, $258000.0 in Q1 2018, and $259000.0 in Q4 2017.